Ftse Mib
33.986,90
1,06%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.243,39
0,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NextTrip Inc (NTRP) NextTrip Inc (NTRP) Notizie

NTRP

NextTrip (NTRP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTRP
DataOraFonteTitoloSimboloCompagnia
04/02/202115:00PR Newswire (US)Synthetic Bryostatin Available to Expand Neurodegenerative Indication TrialsNASDAQ:NTRPNextTrip Inc
02/12/202015:00PR Newswire (US)Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros PharmaceuticalsNASDAQ:NTRPNextTrip Inc
02/12/202014:19Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NTRPNextTrip Inc
27/11/202023:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTRPNextTrip Inc
25/11/202023:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTRPNextTrip Inc
24/11/202019:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NTRPNextTrip Inc
20/11/202015:00PR Newswire (US)Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution DatesNASDAQ:NTRPNextTrip Inc
09/11/202023:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTRPNextTrip Inc
02/11/202023:20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NTRPNextTrip Inc
06/10/202015:00PR Newswire (US)Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's DiseaseNASDAQ:NTRPNextTrip Inc
30/09/202015:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:NTRPNextTrip Inc
30/09/202015:15PR Newswire (US)Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with MetuchenNASDAQ:NTRPNextTrip Inc
30/07/202015:00PR Newswire (US)Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, P...NASDAQ:NTRPNextTrip Inc
10/06/202014:41PR Newswire (US)Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the Nation...NASDAQ:NTRPNextTrip Inc
28/05/202015:00PR Newswire (US)Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Pa...NASDAQ:NTRPNextTrip Inc
26/05/202022:20PR Newswire (US)Neurotrope Announces Investor Update Conference CallNASDAQ:NTRPNextTrip Inc
18/05/202014:45PR Newswire (US)Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health CompanyNASDAQ:NTRPNextTrip Inc
27/04/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTRPNextTrip Inc
24/04/202023:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NTRPNextTrip Inc
17/04/202023:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NTRPNextTrip Inc
13/03/202022:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTRPNextTrip Inc
14/02/202016:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTRPNextTrip Inc
03/02/202023:15GlobeNewswire Inc.XpresSpa Appoints Robert Weinstein to Board of DirectorsNASDAQ:NTRPNextTrip Inc
31/01/202012:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTRPNextTrip Inc
23/01/202015:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTRPNextTrip Inc
22/01/202020:05PR Newswire (US)Neurotrope, Inc. Announces $18 Million Registered Direct OfferingNASDAQ:NTRPNextTrip Inc
22/01/202015:00PR Newswire (US)Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease TrialNASDAQ:NTRPNextTrip Inc
08/10/201914:30PR Newswire (US)Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder ValueNASDAQ:NTRPNextTrip Inc
09/09/201914:35Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:NTRPNextTrip Inc
09/09/201914:30PR Newswire (US)Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disea...NASDAQ:NTRPNextTrip Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTRP

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
AMP
Amplifon
BIT
ENI
Eni
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network